[(3R)-1-azabicyclo[2.2.2]octan-3-yl] N-[2,2-dimethyl-6-[3-(trifluoromethoxy)phenyl]-3H-1-benzofuran-3-yl]carbamate
C25H27F3N2O4 — CID 175766788
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(3R)-1-azabicyclo[2.2.2]octan-3-yl] N-[2,2-dimethyl-6-[3-(trifluoromethoxy)phenyl]-3H-1-benzofuran-3-yl]carbamate
[(3R)-1-azabicyclo[2.2.2]octan-3-yl] N-[2,2-dimethyl-6-[3-(trifluoromethoxy)phenyl]-3H-1-benzofuran-3-yl]carbamate (PubChem CID 175766788) has the molecular formula C25H27F3N2O4 and a molecular weight of 476.50 g/mol. Its IUPAC name is [(3R)-1-azabicyclo[2.2.2]octan-3-yl] N-[2,2-dimethyl-6-[3-(trifluoromethoxy)phenyl]-3H-1-benzofuran-3-yl]carbamate.
Molecular Properties
| Compound Name | [(3R)-1-azabicyclo[2.2.2]octan-3-yl] N-[2,2-dimethyl-6-[3-(trifluoromethoxy)phenyl]-3H-1-benzofuran-3-yl]carbamate |
|---|---|
| PubChem CID | 175766788 |
| Molecular Formula | C25H27F3N2O4 |
| Molecular Weight | 476.50 g/mol |
| Exact Mass | 476.19 |
| IUPAC Name | [(3R)-1-azabicyclo[2.2.2]octan-3-yl] N-[2,2-dimethyl-6-[3-(trifluoromethoxy)phenyl]-3H-1-benzofuran-3-yl]carbamate |
| SMILES | CC1(C)Oc2cc(-c3cccc(OC(F)(F)F)c3)ccc2C1NC(=O)O[C@H]1CN2CCC1CC2 |
| InChI | InChI=1S/C25H27F3N2O4/c1-24(2)22(29-23(31)32-21-14-30-10-8-15(21)9-11-30)19-7-6-17(13-20(19)34-24)16-4-3-5-18(12-16)33-25(26,27)28/h3-7,12-13,15,21-22H,8-11,14H2,1-2H3,(H,29,31)/t21-,22?/m0/s1 |
| InChIKey | NRUXWBZCLUZZDO-HMTLIYDFSA-N |
| XLogP | 5.28 |
| TPSA | 60.03 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 476.50 |
| LogP ≤ 5 | 5.28 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175766788 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.